{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:35:45Z","timestamp":1788388545835,"version":"build-2803163510"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009128","name":"Research for Patient Benefit Programme","doi-asserted-by":"publisher","award":["NIHR202781"],"award-info":[{"award-number":["NIHR202781"]}],"id":[{"id":"10.13039\/501100009128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bullous pemphigoid (BP) is a serious autoimmune skin disease affecting older people. Given the highly prevalent polypharmacy in older people, identifying drug combinations associated with high BP risk is needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To identify drug combinations frequently prescribed for older people prior to BP using association rule mining (ARM) and to estimate their risk of developing BP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a nested case\u2013control study using UK Clinical Practice Research Datalink primary care records (1998\u20132021). ARM was used to identify the 10 most common drug class or active substance pairs most likely coprescribed (lift) on the same day and within 30\u2005days of one another (sensitivity analysis). Fold change (FC; case-to-control lift ratio) was used to identify combinations with greater lift in cases. Multivariable conditional logistic regression was performed to estimate BP risk following combinations and their constituent drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 16 844 cases and 79 493 controls, the most frequent drug class combinations associated with increased BP risk with greater lift in cases were angiotensin-converting enzyme inhibitors (ACEIs)\u2013statins (FC 1.31; FC in sensitivity analysis 1.18), antiplatelets\u2013statins (1.23; 1.11), proton pump inhibitors (PPIs)\u2013antiplatelets (1.22; 1.14), PPIs\u2013statins (1.22; 1.14) and ACEIs\u2013antiplatelets (1.20; 1.09). Substance combinations with a greater lift in cases included ramipril\u2013simvastatin (FC 1.30), simvastatin\u2013aspirin (1.21), ramipril\u2013aspirin (1.19) and bendroflumethiazide\u2013aspirin (1.16). The results of sensitivity analyses for substances were similar. BP risk following drug combinations was lower than after single drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Using ARM we found that the most frequently prescribed drug combinations associated with increased BP risk were used to treat cardiovascular diseases and hypertension. Patients should be vigilant for skin changes following these drugs rather than avoid them.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ced\/llaf362","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T11:33:51Z","timestamp":1754393631000},"page":"27-34","source":"Crossref","is-referenced-by-count":4,"title":["Determining the most frequent combinations of drugs prescribed prior to bullous pemphigoid diagnosis using association rule mining: a UK population-based case\u2013control study"],"prefix":"10.1093","volume":"51","author":[{"given":"Mikolaj","family":"Swiderski","sequence":"first","affiliation":[{"name":"School of Medicine, University of Nottingham , Nottingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazziela","family":"Figueredo","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Nottingham , Nottingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Vinogradova","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Nottingham , Nottingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger D","family":"Knaggs","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Nottingham , Nottingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen\u00a0E","family":"Harman","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospitals of Leicester NHS Trust , Leicester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4920-6718","authenticated-orcid":false,"given":"Rowan H","family":"Harwood","sequence":"additional","affiliation":[{"name":"School of Health Sciences, University of Nottingham , Nottingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhore","family":"Prasad","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Nottingham , Nottingham ,","place":["UK"]},{"name":"Department of Population Health Sciences, King\u2019s College London , London ,","place":["UK"]},{"name":"NHS Nottingham and Nottinghamshire , Nottingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica S M","family":"Persson","sequence":"additional","affiliation":[{"name":"Swedish Rheumatism Association , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carron","family":"Layfield","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Nottingham , Nottingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Gran","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Nottingham , Nottingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"2025122312175578400_llaf362-B1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/bjd.19022","article-title":"Incidence, prevalence and mortality of bullous pemphigoid in England 1998\u20132017: a population-based cohort study","volume":"184","author":"Persson","year":"2021","journal-title":"Br J Dermatol"},{"key":"2025122312175578400_llaf362-B2","doi-asserted-by":"crossref","first-page":"j2169","DOI":"10.1136\/bmj.j2169","article-title":"Bullous pemphigoid and pemphigus vulgaris","volume":"357","author":"Kayani","year":"2017","journal-title":"BMJ"},{"key":"2025122312175578400_llaf362-B3","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3390\/biom10101432","article-title":"Bullous pemphigoid: trigger and predisposing factors","volume":"10","author":"Moro","year":"2020","journal-title":"Biomolecules"},{"key":"2025122312175578400_llaf362-B4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1365-2133.2012.11108.x","article-title":"Clinical presentation and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort","volume":"167","author":"della Torre","year":"2012","journal-title":"Br J Dermatol"},{"key":"2025122312175578400_llaf362-B5","doi-asserted-by":"crossref","first-page":"adv00224","DOI":"10.2340\/00015555-3457","article-title":"A systematic review of drug-induced pemphigoid","volume":"100","author":"Verheyden","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"2025122312175578400_llaf362-B6","doi-asserted-by":"crossref","first-page":"e904","DOI":"10.3399\/BJGP.2020.0870","article-title":"Long-term oral prednisolone exposure in primary care for bullous pemphigoid: population-based study","volume":"71","author":"Persson","year":"2021","journal-title":"Br J Gen Pract"},{"key":"2025122312175578400_llaf362-B7","author":"Sykes"},{"issue":"Suppl. 2","key":"2025122312175578400_llaf362-B8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13223-018-0278-1","article-title":"An introduction to immunology and immunopathology","volume":"14","author":"Marshall","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"2025122312175578400_llaf362-B9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1590\/abd1806-4841.20199007","article-title":"Bullous pemphigoid","volume":"94","author":"Miyamoto","year":"2019","journal-title":"An Bras Dermatol"},{"key":"2025122312175578400_llaf362-B10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jamadermatol.2020.1587","article-title":"Association between medication use and bullous pemphigoid: a systematic review and meta-analysis","volume":"156","author":"Liu","year":"2020","journal-title":"JAMA Dermatol"},{"key":"2025122312175578400_llaf362-B11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/2013.jamadermatol.376","article-title":"The associations between bullous pemphigoid and drug use: a UK case\u2013control study","volume":"149","author":"Lloyd-Lavery","year":"2013","journal-title":"JAMA Dermatol"},{"key":"2025122312175578400_llaf362-B12","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/dc19-0409","article-title":"Dipeptidyl peptidase 4 inhibitors and the risk of bullous pemphigoid among patients with type 2 diabetes","volume":"42","author":"Douros","year":"2019","journal-title":"Diabetes Care"},{"key":"2025122312175578400_llaf362-B13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/epirev\/mxs009","article-title":"Multimorbidity in older adults","volume":"35","author":"Salive","year":"2013","journal-title":"Epidemiol Rev"},{"key":"2025122312175578400_llaf362-B14","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/S2589-7500(19)30012-3","article-title":"A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service","volume":"1","author":"Kuan","year":"2019","journal-title":"Lancet Digit Health"},{"key":"2025122312175578400_llaf362-B15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","article-title":"Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences","volume":"12","author":"Pazan","year":"2021","journal-title":"Eur Geriatr Med"},{"key":"2025122312175578400_llaf362-B16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1006\/pmed.1994.1093","article-title":"Nested case\u2013control studies","volume":"23","author":"Ernster","year":"1994","journal-title":"Prev Med"},{"key":"2025122312175578400_llaf362-B17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2288-8-48","article-title":"Advantages of the nested case\u2013control design in diagnostic research","volume":"8","author":"Biesheuvel","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"2025122312175578400_llaf362-B18","author":"Medicines and Healthcare products Regulatory Agency"},{"key":"2025122312175578400_llaf362-B19","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"2025122312175578400_llaf362-B20","doi-asserted-by":"crossref","first-page":"e035934","DOI":"10.1136\/bmjopen-2019-035934","article-title":"Validation study of bullous pemphigoid and pemphigus vulgaris recording in routinely collected electronic primary healthcare records in England","volume":"10","author":"Persson","year":"2020","journal-title":"BMJ Open"},{"key":"2025122312175578400_llaf362-B21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pds.1115","article-title":"The relationship between time since registration and measured incidence rates in the General Practice Research Database","volume":"14","author":"Lewis","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025122312175578400_llaf362-B22","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1136\/oem.2004.014472","article-title":"An incidence density sampling program for nested case\u2013control analyses","volume":"61","author":"Richardson","year":"2004","journal-title":"Occup Environ Med"},{"key":"2025122312175578400_llaf362-B23","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/bjd.14815","article-title":"Statin use and the risk of herpes zoster: a nested case\u2013control study using primary care data from the UK Clinical Research Practice Datalink","volume":"175","author":"Matthews","year":"2016","journal-title":"Br J Dermatol"},{"key":"2025122312175578400_llaf362-B24","first-page":"487","volume-title":"Proceedings of the 20th International Conference on Very Large Data Bases","author":"Agrawal","year":"1994"},{"key":"2025122312175578400_llaf362-B25","author":"R Core Team"},{"key":"2025122312175578400_llaf362-B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v014.i15","article-title":"arules \u2013 a computational environment for mining association rules and frequent item sets","volume":"14","author":"Hahsler","year":"2005","journal-title":"J Stat Softw"},{"key":"2025122312175578400_llaf362-B27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12874-022-01755-x","article-title":"Forecasting COVID-19 cases using time series modeling and association rule mining","volume":"22","author":"Somyanonthanakul","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"2025122312175578400_llaf362-B28","volume-title":"Visualizing association rules for text mining","author":"Wong","year":"24\u201329  1999"},{"key":"2025122312175578400_llaf362-B29","author":"IBM Corp"},{"key":"2025122312175578400_llaf362-B30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21780","article-title":"Clinical effectiveness and cost-\u00adeffectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling","volume":"21","author":"Miani","year":"2017","journal-title":"Health Technol Assess"},{"key":"2025122312175578400_llaf362-B31","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/bjd.15405","article-title":"Increased frequency of multiple sclerosis among patients with bullous pemphigoid: a population-based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid","volume":"176","author":"Kibsgaard","year":"2017","journal-title":"Br J Dermatol"},{"key":"2025122312175578400_llaf362-B32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jdin.2023.04.014","article-title":"Characteristics, treatment patterns, health care resource utilization and costs in patients with bullous pemphigoid: a retrospective analysis of US health insurance claims data","volume":"13","author":"Stirnadel-Farrant","year":"2023","journal-title":"JAAD Int"},{"key":"2025122312175578400_llaf362-B33","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/jdv.14312","article-title":"Multimorbidity in bullous pemphigoid: a case\u2013control analysis of bullous pemphigoid patients with age- and gender-matched controls","volume":"31","author":"Sim","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025122312175578400_llaf362-B34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2296-11-1","article-title":"Adaptation and validation of the Charlson Index for Read\/OXMIS coded databases","volume":"11","author":"Khan","year":"2010","journal-title":"BMC Fam Pract"},{"key":"2025122312175578400_llaf362-B35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/bjd\/ljae416","article-title":"The association between drugs and vaccines commonly prescribed to older people and bullous pemphigoid: a case\u2013control study","volume":"192","author":"Swiderski","year":"2025","journal-title":"Br J Dermatol"},{"key":"2025122312175578400_llaf362-B36","author":"Medicines and Healthcare products Regulatory Agency"},{"key":"2025122312175578400_llaf362-B37","volume-title":"British National Formulary (BNF)","year":"2019"},{"key":"2025122312175578400_llaf362-B38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fmed.2018.00238","article-title":"Comorbidities and treatment strategies in bullous pemphigoid: an appraisal of the existing literature","volume":"5","author":"Bech","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"2025122312175578400_llaf362-B39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-4362.1992.tb03517.x","article-title":"Two-step\u2019 pemphigus induction by ACE-inhibitors","volume":"31","author":"Ruocco","year":"1992","journal-title":"Int J Dermatol"},{"key":"2025122312175578400_llaf362-B40","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/j.2040-4603.2011.tb00347.x","article-title":"The kallikrein\u2013kinin system as a regulator of cardiovascular and renal function","volume":"1","author":"Rhaleb","year":"2011","journal-title":"Compr Physiol"},{"key":"2025122312175578400_llaf362-B41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.biotechadv.2007.02.003","article-title":"Isolation and affinity maturation of hapten-specific antibodies","volume":"25","author":"Sheedy","year":"2007","journal-title":"Biotechnol Adv"},{"key":"2025122312175578400_llaf362-B42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jaad.2010.02.032","article-title":"A case of bullous pemphigoid induced by aspirin","volume":"65","author":"Durdu","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2025122312175578400_llaf362-B43","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/jid.2010.301","article-title":"Risk factors for bullous pemphigoid in the elderly: a prospective case\u2013control study","volume":"131","author":"Bastuji-Garin","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"2025122312175578400_llaf362-B44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jdin.2021.02.002","article-title":"The association between statins and subsequent risk of bullous pemphigoid: a population-based cohort study","volume":"3","author":"Chang","year":"2021","journal-title":"JAAD Int"},{"key":"2025122312175578400_llaf362-B45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10462-016-9483-9","article-title":"Applications of association rule mining in health informatics: a survey","volume":"47","author":"Altaf","year":"2017","journal-title":"Artif Intell Rev"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf362\/63962291\/llaf362.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/1\/27\/63962291\/llaf362.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/1\/27\/63962291\/llaf362.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T17:18:08Z","timestamp":1766510288000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/51\/1\/27\/8222864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,8,6]]},"published-print":{"date-parts":[[2025,12,23]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf362","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,8,6]]}}}